FindTrial
Sign In

Hearing impairment in patients with OSMF

Evaluation & comparison of hearing impairment in relation to Eustachian tube dysfunction and levels of trace elements in serum of patients with Oral Submucous Fibrosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/10/010161
Enrollment
200
Registered
2017-10-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- suffering with oral submucous fibrosis

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects ranging between the age group of 13 to 35 yrs. 2. Systemically healthy subjects. 3. Patients having OSMF

Exclusion criteria

Exclusion criteria: 1. Patients with more than one type of lesion. 2. Patients with pathology of the middle ear, tympanic membrane perforation, cholesteotoma. 3. Other condition causing restrictive in mouth opening. 4. Patients with H/O drug intake containing iron, copper,& zinc. 5. Pregnant women & patients on oral contraceptives. 6. Patients who has undergone any treatment for OSMF.

Design outcomes

Primary

MeasureTime frame
Trace elements Copper Iron and ZincTimepoint: 12 months—

Secondary

MeasureTime frame
Audiometry anaylsisTimepoint: 12 months—

Countries

India

Contacts

Public ContactDr Surekha Rathod

Department of Periodotntics and Implantology, VSPM Dental College and Research Centre, Nagpur

drsurekhar@gmail.com9011071477

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026